Zoledronic Acid Injection, Solution
Product Images NDC 55111-688

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Zoledronic Acid (NDC 55111-688). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dr.reddy's Laboratories Ltd, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton (Carton)

Carton (Carton)
This is a description for Zoledronic Acid Injection, a solution for intravenous infusion administered as a single solution through a separate vented infusion line. The package contains one 100 mL single-dose bottle of sterile solution with a concentration of 5mg/100 mL (0.05 mg/mL). It is important not to mix with calcium-containing solutions. The package insert should be consulted for dosage and administration instructions. The solution contains zoledronic acid monohydrate, mannitol, USP, sodium citrate, ISR, and water for injection purposes. It is recommended that parenteral drug products be inspected visually for particulate matter and discoloration prior to administration. The solution should be stable for 24 hours at a temperature ranging from 36 to 46 degrees Celsius. The product should be refrigerated and allowed to reach room temperature before being administered. The product should be stored at a controlled room temperature between 20°C to 25°C (66°F to T) and should not be exposed to temperatures outside of this range.*
FDA Label Image

Figure2 (Figure2)

Figure2 (Figure2)
This document appears to be a chart showing the therapeutic response over time for two types of injections (zoledronic acid and risedronate) with respect to serum alkaline phosphatase (SAP) normalization rate and response rate. The chart displays data points at different time intervals (10, 28, 63, and 182 days) for each injection type. The SAP normalization rate for both injections is shown to increase over time. The chart also includes a note stating that the data is statistically significant (P < 0.001).*
FDA Label Image

Structure (Structure)

FDA Label Image

Vial (Vial)

Vial (Vial)
This is a description of a Zoledronic Acid Injection solution for intravenous infusion. The solution is sterile and must not be mixed with calcium-containing solutions. It is advised to administer the solution through a separate vented infusion line as a single intravenous solution. The dosage and administration details are provided in the package insert. The infusion time should not be less than 15 minutes. The NDC code for the solution is 55111-688-52.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.